LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Osi Pharmaceuticals
BioCentury
|
Oct 21, 2024
Product Development
EGFR: A best-in-class strategy study
The target is one of industry’s most notable case studies in continued product differentiation and market growth
Read More
BioCentury
|
Jun 28, 2022
Emerging Company Profile
Sling: advancing an oral alternative to Tepezza for thyroid eye
First company created by sole investor TPG cleared for Phase IIb trial of asset Astellas had studied in cancer
Read More
BioCentury
|
Sep 11, 2021
Finance
Fred Frank, co-founder of the biotech industry, is dead at 89
His influence can be found on deals that built biopharma ecosystem
Read More
BioCentury
|
Dec 14, 2018
Financial News
Versant launches Black Diamond to mine allosteric mutant oncogenes
Read More
BioCentury
|
Dec 11, 2018
Financial News
Versant launches Black Diamond to mine allosteric mutant oncogenes
Read More
BioCentury
|
Dec 11, 2018
Emerging Company Profile
Black Diamond: Mapping allostery
Black Diamond debuts with plans to identify, target allosteric mutant oncogenes
Read More
BioCentury
|
Jun 24, 2016
Company News
Management tracks
Read More
BioCentury
|
Sep 22, 2014
Company News
Ophthotech, Novartis deal
Read More
BioCentury
|
Aug 18, 2014
Clinical News
Fovista: Phase IIa started
Read More
BioCentury
|
Aug 4, 2014
Product Development
Beyond biopsy
Why AZ chose two partners for non-invasive companion diagnostics for NSCLC
Read More
Items per page:
10
1 - 10 of 792